IMU 6.82% 4.1¢ imugene limited

Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-54

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 134 Posts.
    lightbulb Created with Sketch. 40
    I’ve looked at this a few times, as I’m curious as well, they’ve done I think 2 updates on cohorts but can only find one.
    On my mobile currently but found 7th April announcement for 2nd cohort and follow up of first.
    after 43 days
    1 complete response
    3 stable disease
    1 progressing

    and said first cohort at 86 days had
    1 complete response
    1 stable disease


    I thought there was another comment somewhere about some more responses in first cohort but maybe misremembering.

    Also in regards to the 22 enrolled, I wonder if that many have been dosed or whether that’s planned for the part B, as the wording on the 7th makes it seem like only 5 were in that cohort. Unless by time of announcement hadn’t hit 43 days yet for more of them?

    Does anyone have any idea regarding patients dosed?

    Cheers


 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
-0.003(6.82%)
Mkt cap ! $304.9M
Open High Low Value Volume
4.3¢ 4.4¢ 4.1¢ $1.607M 38.52M

Buyers (Bids)

No. Vol. Price($)
23 4542680 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 1675759 9
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.